{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:18:21Z","timestamp":1789967901920,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.canrad.2012.06.005","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T21:31:49Z","timestamp":1350941509000},"page":"601-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Radiotherapy combined with cetuximab for locally advanced head and neck cancer: Results and toxicity"],"prefix":"10.1016","volume":"16","author":[{"given":"C.M.","family":"Acevedo-Henao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Miglierini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lefur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Pradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2012.06.005_bib0005","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(08)60728-X","article-title":"Head and neck cancer","volume":"371","author":"Argiris","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2012.06.005_bib0010","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMra0707975","article-title":"Recent advances in head and neck cancer","volume":"359","author":"Haddad","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2012.06.005_bib0015","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.ejca.2010.05.015","article-title":"Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?","volume":"46","author":"Bourhis","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2012.06.005_bib0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1748-717X-6-54","article-title":"Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy","volume":"6","author":"Oksuz","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2012.06.005_bib0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2012.06.005_bib0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2012.06.005_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2012.06.005_bib0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.canrad.2007.11.003","article-title":"Chemoradiotherapy in head and neck squamous cell carcinoma: focus on targeted therapies","volume":"12","author":"Bozec","year":"2008","journal-title":"Cancer\/Radiother"},{"key":"10.1016\/j.canrad.2012.06.005_bib0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2010.09.024","article-title":"The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy\u00a0\u2013\u00a0results from the randomized DAHANCA 5 study","volume":"98","author":"Hoff","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2012.06.005_bib0050","first-page":"118","article-title":"Cetuximab-associated pulmonary toxicity","volume":"8","author":"Chua","year":"2009","journal-title":"Clin Colorectal Cancer"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321812003769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321812003769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:19:34Z","timestamp":1761135574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321812003769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1278321812003769"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2012.06.005","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy combined with cetuximab for locally advanced head and neck cancer: Results and toxicity","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2012.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}